JPWO2021195066A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021195066A5
JPWO2021195066A5 JP2022557683A JP2022557683A JPWO2021195066A5 JP WO2021195066 A5 JPWO2021195066 A5 JP WO2021195066A5 JP 2022557683 A JP2022557683 A JP 2022557683A JP 2022557683 A JP2022557683 A JP 2022557683A JP WO2021195066 A5 JPWO2021195066 A5 JP WO2021195066A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
epilepsy
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022557683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518838A5 (https=
JP7838820B2 (ja
JP2023518838A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/023653 external-priority patent/WO2021195066A2/en
Publication of JP2023518838A publication Critical patent/JP2023518838A/ja
Publication of JP2023518838A5 publication Critical patent/JP2023518838A5/ja
Publication of JPWO2021195066A5 publication Critical patent/JPWO2021195066A5/ja
Application granted granted Critical
Publication of JP7838820B2 publication Critical patent/JP7838820B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022557683A 2020-03-23 2021-03-23 Kcnt1阻害剤及び使用方法 Active JP7838820B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062993359P 2020-03-23 2020-03-23
US62/993,359 2020-03-23
PCT/US2021/023653 WO2021195066A2 (en) 2020-03-23 2021-03-23 Kcnt1 inhibitors and methods of use

Publications (4)

Publication Number Publication Date
JP2023518838A JP2023518838A (ja) 2023-05-08
JP2023518838A5 JP2023518838A5 (https=) 2024-04-03
JPWO2021195066A5 true JPWO2021195066A5 (https=) 2024-04-03
JP7838820B2 JP7838820B2 (ja) 2026-04-01

Family

ID=77892612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022557683A Active JP7838820B2 (ja) 2020-03-23 2021-03-23 Kcnt1阻害剤及び使用方法

Country Status (11)

Country Link
US (1) US20230285377A1 (https=)
EP (1) EP4125831A4 (https=)
JP (1) JP7838820B2 (https=)
KR (1) KR20230005168A (https=)
CN (2) CN121868303A (https=)
AU (1) AU2021241530A1 (https=)
BR (1) BR112022019041A2 (https=)
CA (1) CA3176609A1 (https=)
IL (1) IL296649A (https=)
MX (2) MX2022011813A (https=)
WO (1) WO2021195066A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250172745A (ko) * 2019-05-03 2025-12-09 프락시스 프리시젼 메디신즈, 인크. Kcnt1 억제제 및 사용 방법
KR20220016086A (ko) * 2019-05-03 2022-02-08 프락시스 프리시젼 메디신즈, 인크. Kcnt1 억제제 및 사용 방법
JP7699836B2 (ja) 2020-02-28 2025-06-30 プラクシス プレシジョン メディシンズ, インコーポレイテッド Kcnt1阻害剤、および使用方法
US11773088B2 (en) 2020-11-02 2023-10-03 Praxis Precision Medicines, Inc. KCNT1 inhibitors and methods of use
WO2023211854A1 (en) * 2022-04-25 2023-11-02 Praxis Precision Medicines, Inc. Kcnt1 inhibitors comprising a thiazole core and methods of use
WO2023211850A1 (en) * 2022-04-25 2023-11-02 Praxis Precision Medicines, Inc. Kcnt1 inhibitors comprising an isoxazole or oxadiazole core and methods of use
IL316283A (en) * 2022-04-25 2024-12-01 Praxis Prec Medicines Inc KCNT1 inhibitors comprising a pyrazole core and methods of use
EP4630399A1 (en) * 2022-12-05 2025-10-15 Praxis Precision Medicines, Inc. Kcnt1 inhibitors comprising a phenyl, pyridine, or pyrimidine core and methods of use
TW202502311A (zh) * 2023-03-29 2025-01-16 美商默沙東有限責任公司 Il4i1抑制劑及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003221322A1 (en) * 2002-03-07 2003-09-16 Sds Biotech K.K. Substituted isoxazole alkylamine derivative and agri- and horticultural fungicide
KR101195801B1 (ko) * 2004-06-18 2012-11-05 밀레니엄 파머슈티컬스 인코퍼레이티드 Xa 인자 억제제
ATE478847T1 (de) * 2006-09-15 2010-09-15 Pfizer Substituierte pyridylmethylbicyclocarboxyamidverbindungen
US9321727B2 (en) * 2011-06-10 2016-04-26 Hoffmann-La Roche Inc. Pyridine derivatives as agonists of the CB2 receptor
TW201642855A (zh) * 2015-03-10 2016-12-16 健臻公司 用於治療蛋白質病變之方法
EP3275440B1 (en) * 2015-03-25 2022-05-04 National Center for Geriatrics and Gerontology Novel oxadiazole derivative and pharmaceutical containing same

Similar Documents

Publication Publication Date Title
JP5690823B2 (ja) Jak受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物
CA2966423C (en) Potent gamma-secretase modulators
CN101918079A (zh) 蛋白激酶抑制剂及其用途
JP2005514398A5 (https=)
US6451796B1 (en) Fused pyrazine compounds
JP2004509113A5 (https=)
JP2005047930A5 (https=)
ZA200408711B (en) Novel thiophene amidines, composition thereof, and methods of treating complement-mediated diseases and conditions
JP2014506599A5 (https=)
JP2013542996A5 (https=)
JPWO2021195066A5 (https=)
MX2014008143A (es) Inhibidores de bromodominio.
CA3157026A1 (en) Arylmethylene aromatic compounds as kv1.3 potassium shaker channel blockers
JP2008513508A5 (https=)
CA2747022A1 (en) Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
CA3116931A1 (en) Heterocyclic compounds as bet inhibitors
AU2004229466A1 (en) Imidazole derivatives for treatment of allergic and hyperproliferative disorders
JP2003513066A5 (https=)
JP2002544258A (ja) イオンチャネル調節剤
EP2340249B1 (en) Poly-heteroaryl derivatives for the treatment of cancer
JPWO2020227101A5 (https=)
CN110156782B (zh) 作为pi3k/mtor抑制剂的吡啶基取代的稠合喹啉化合物
US10669265B2 (en) Pyridyl benzothiophenes as kinase inhibitors
JPWO2022010880A5 (https=)
CA3209830A1 (en) Tyk2 inhibitor compound containing bicyclic ring